Loxo,Bayer gets U.S approval for cancer drug Larotrectinib Medical Dialogues Bureau28 Nov 2018 9:06 AM ISTNew Delhi: A Loxo Oncology Inc drug larotrectinib shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation...